You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 10, March 10, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Crossroads: Conferences With Patients and Doctors
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Renal Diseases
 •Dialysis
 •Renal Diseases, Other
 •Alert me on articles by topic

CLINICIAN'S CORNER
A 43-Year-Old Woman With Chronic Renal Insufficiency

Glenn M. Chertow, MD, MPH, Discussant

JAMA. 2004;291:1252-1259.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

DR SHIP: Mrs C is a 43-year-old woman who has had renal insufficiency for 23 years. She works as a nurse assistant part time and lives with her husband and son outside Boston. She has indemnity insurance.

Mrs C was first found to have protein in her urine when she was 20 years of age. No intervention was made at that time. She was followed up clinically until her 30s, when a new internist referred her to a kidney specialist. In 1995, she underwent a kidney biopsy and was diagnosed as having focal segmental glomerular sclerosis. Soon after, she became pregnant and was told that her pregnancy might speed the progression of her kidney disease. She chose to proceed and had a healthy pregnancy and delivery without any symptoms or complications.

During the past few years, Mrs C's nephrologist has told her . . . [Full Text of this Article]

MRS C: HER VIEW

AT THE CROSSROADS: QUESTIONS FOR DR CHERTOW

Epidemiology of ESRD in the United States

Screening for and Slowing Progression of Chronic Kidney Disease

Clinical and Laboratory Indicators of Uremia

Criteria for Selecting Treatment Options in ESRD

Geographic and Other Sources of Variation in Modality Selection

Contraindications to Specific ESRD Treatment Options

To Fear or to Embrace Dialysis?

Specific Risks and Benefits

Costs of Dialysis

Recommendations for Mrs C

The Future

QUESTIONS AND DISCUSSION

Author Affiliation: Dr Chertow is Director of Clinical Services, Divisions of Nephrology, Moffitt-Long Hospitals and UCSF-Mt Zion Medical Center, Department of Medicine, University of California, San Francisco.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A 43-Year-Old Woman With End-Stage Renal Disease, 2 Years 6 Months Later
Ship
JAMA 2005;294:841-841.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.